Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|August 1, 1991
Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapyJ M Diver, T Schollaardt, H R Rabin, et al.The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|February 21, 2012
Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomalleiL E Bryan, S Wong, D E Woods, et al.Canadian Journal of Microbiology|December 1, 1986
Lack of protection against ascending Escherichia coli pyelonephritis in diabetic rats following immunization with purified lipopolysaccharideL E Bryan, T Schollaardt, C Y Pak, et al.Antimicrobial Agents and Chemotherapy|October 1, 1976
Classification of R plasmids by incompatibility in Pseudomonas aeruginosaH Sagai, K Hasuda, S Iyobe, et al.Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|September 1, 1987
Possible mechanisms in the pathogenesis of virus-induced diabetes mellitusJ W Yoon, H M Eun, K Essani, et al.The Journal of Antimicrobial Chemotherapy|June 1, 1990
Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiencyS Chamberland, F Malouin, H R Rabin, et al.Journal of Clinical Microbiology|September 1, 1984
Latex agglutination test for detection of Clostridium difficile toxin in stool samplesM S Shahrabadi, L E Bryan, D Gaffney, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1982
Immune response of the mouse to gram-negative bacterial outer membrane extracts as assessed with monoclonal antibodiesE B Mackie, B M Longenecker, H R Rabin, et al.Antimicrobial Agents and Chemotherapy|September 1, 1987
Mechanism of Pseudomonas aeruginosa persistence during treatment with broad-spectrum cephalosporins of lung infections in patients with cystic fibrosisA B Schryvers, J Ogunariwo, S Chamberland, et al.Antimicrobial Agents and Chemotherapy|May 1, 1973
Characteristics of R931 and other Pseudomonas aeruginosa R factorsL E Bryan, S D Semaka, H M Van den Elzen, et al.Pageof 9